001445385 000__ 05607cam\a2200541Ii\4500
001445385 001__ 1445385
001445385 003__ OCoLC
001445385 005__ 20230310003828.0
001445385 006__ m\\\\\o\\d\\\\\\\\
001445385 007__ cr\un\nnnunnun
001445385 008__ 220326s2022\\\\si\\\\\\o\\\\\000\0\eng\d
001445385 019__ $$a1306023115$$a1306055204
001445385 020__ $$a9789811643927$$q(electronic bk.)
001445385 020__ $$a981164392X$$q(electronic bk.)
001445385 020__ $$z9789811643910
001445385 020__ $$z9811643911
001445385 0247_ $$a10.1007/978-981-16-4392-7$$2doi
001445385 035__ $$aSP(OCoLC)1305911127
001445385 040__ $$aYDX$$beng$$erda$$epn$$cYDX$$dGW5XE$$dEBLCP$$dOCLCO$$dUKAHL$$dOCLCQ
001445385 049__ $$aISEA
001445385 050_4 $$aRC756$$b.A38 2022
001445385 08204 $$a616.2/4061$$223
001445385 24500 $$aAdvanced drug delivery strategies for targeting chronic inflammatory lung diseases /$$cDinesh Kumar Chellappan, Kavita Pabreja, Md. Faiyazuddin, editors.
001445385 264_1 $$aSingapore :$$bSpringer,$$c[2022]
001445385 264_4 $$c©2022
001445385 300__ $$a1 online resource
001445385 336__ $$atext$$btxt$$2rdacontent
001445385 337__ $$acomputer$$bc$$2rdamedia
001445385 338__ $$aonline resource$$bcr$$2rdacarrier
001445385 5050_ $$aChapter 1. An introduction to respiratory diseases and an emerging need for efficient drug delivery systems -- Chapter 2. Inflammatory respiratory diseases: Correlation between Lung cancer and CoVid-19 -- Chapter 3. Advancements in translational respiratory research using nanotechnology -- Chapter 4. Chemical moieties as advanced therapeutics for targeting respiratory disorders -- Chapter 5. Phytochemicals and their nanoformulations targeted for pulmonary diseases -- Chapter 6. Nanocarriers: an advanced and highly effective approach for targeting chronic lung diseases -- Chapter 7. Vesicular drug delivery systems in respiratory diseases -- Chapter 8. Nanoparticles in chronic respiratory diseases -- Chapter 9. Applications of nanotechnology in pulmonary disease diagnosis -- Chapter 10. Nanotechnology in pulmonary disease diagnosis -- Chapter 11. Recent trends in Nanomedicine for diagnosis and treatment of pulmonary diseases -- Chapter 12. Strategies for enhanced drug targeting to inflamed lungs: Novel perspectives -- Chapter 13. Solid-Lipid Nanocarriers (SLN⁰́₉s) based drug delivery for treating various pulmonary diseases -- Chapter 14. Microparticles, microspheres and microemulsions as pulmonary drug delivery systems for the treatment of respiratory diseases -- Chapter 15. Microparticles, microspheres and microemulsions in respiratory diseases -- Chapter 16. Advanced drug delivery systems targeting the immune system at cellular level in chronic respiratory diseases -- Chapter 17. Targeted Micellar Systems for Pulmonary Disease Intervention -- Chapter 18. Polymeric and inorganic nanoparticles targeting chronic respiratory diseases -- Chapter 19. Mucoadhesive drug delivery system in chronic respiratory diseases -- Chapter 20. Liposomal Drug Delivery: Therapeutic Applications in Chronic Respiratory Diseases -- Chapter 21. Biologics and vaccines for nasal and pulmonary drug delivery -- Chapter 22. Drug delivery systems for respiratory infections -- Chapter 23. Cell and Gene Therapies for Chronic Inflammatory Lung Diseases - Emerging Technological Trends and Advancements in Respiratory Medicine -- Chapter 24. Targeting biofilms in respiratory diseases using novel drug delivery systems -- Chapter 25. Advanced nanomaterials for drug delivery in chronic respiratory disorders -- Chapter 26. Emerging technological trends and advancements in respiratory medicine -- Chapter 27. Pulmonary pharmacokinetics and Biophysics -- Chapter 28. Clinical trials on novel advanced drugs for chronic respiratory disorders.
001445385 506__ $$aAccess limited to authorized users.
001445385 520__ $$aThis book describes the growing clinical and healthcare relevance of nano-therapeutics in treating respiratory diseases. It begins with a brief introduction on the different types of nanoparticles in respiratory disease conditions. It further discusses the current trends in understanding the disease pathology using different in vitro and in vivo models, which are important towards the onsite clinical applications and development of new therapeutics. The book includes exciting topics such as formulation of these nanoparticles, targeting various organelles etc. It also describes the future prospects and challenges in the field. Different chapters are written by researchers actively working in the area of pulmonary diseases. This book is designed to address the requirements of both beginners and specialized scientists involved in pulmonary research. The contents include basic concepts followed by advanced state-of-art monitoring and treatment of diseases. The book is meant for researchers and industry experts in nanotechnology, pharmaceutical sciences and drug design.
001445385 588__ $$aDescription based on print version record.
001445385 650_0 $$aLungs$$xDiseases$$xTreatment.
001445385 650_0 $$aDrug delivery systems.
001445385 650_6 $$aPoumons$$xMaladies$$xTraitement.
001445385 650_6 $$aSystèmes d'administration de médicaments.
001445385 655_0 $$aElectronic books.
001445385 7001_ $$aChellappan, Dinesh Kumar,$$eeditor.
001445385 7001_ $$aPabreja, Kavita,$$eeditor.
001445385 7001_ $$aFaiyazuddin, Md,$$eeditor.
001445385 77608 $$iPrint version:$$tAdvanced drug delivery strategies for targeting chronic inflammatory lung diseases.$$dSingapore : Springer, 2022$$z9789811643910$$w(OCoLC)1295100079
001445385 852__ $$bebk
001445385 85640 $$3Springer Nature$$uhttps://univsouthin.idm.oclc.org/login?url=https://link.springer.com/10.1007/978-981-16-4392-7$$zOnline Access$$91397441.1
001445385 909CO $$ooai:library.usi.edu:1445385$$pGLOBAL_SET
001445385 980__ $$aBIB
001445385 980__ $$aEBOOK
001445385 982__ $$aEbook
001445385 983__ $$aOnline
001445385 994__ $$a92$$bISE